May 18, 2024 10:24 PM
BACK TO TOP
KSE100
75,342.34
411.65
(0.55%)
ALLSHR
48,769.45
232.51
(0.48%)
KSE30
24,214.28
68.60
(0.28%)
KMI30
124,073.59
577.66
(0.47%)
BKTI
18,555.77
-28.30
(-0.15%)
OGTI
17,849.85
38.86
(0.22%)
KMIALLSHR
34,803.01
229.59
(0.66%)
PSXDIV20
30,419.07
58.18
(0.19%)
UPP9
21,900.68
48.39
(0.22%)
NITPGI
17,954.96
39.12
(0.22%)
NBPPGI
20,134.41
48.08
(0.24%)
MZNPI
16,339.26
61.82
(0.38%)
JSMFI
19,812.47
36.08
(0.18%)
ACI
12,490.40
104.41
(0.84%)
JSGBKTI
19,779.39
-3.30
(-0.02%)
MII30
11,309.60
58.69
(0.52%)
HBLTTI
13,907.82
13-05-2024
0.00
(0.00%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.137.26
1.41
(1.04%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, May 17, 2024 5:00 PM
REG
FUT
ODL
Open
136.25
High
138.20
Low
135.00
Volume
138,000
CIRCUIT BREAKER
125.66 — 146.04
DAY RANGE
135.00 — 138.20
52-WEEK RANGE
68.00 — 141.50
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
135.85
VAR
19.50
HAIRCUT
30.00
P/E Ratio (TTM) **
65.05
1-Year Change *
63.40%
YTD Change *
65.39%

No record found

Last update: Fri, May 17, 2024 4:29 PM
Open
0.00
High
137.20
Low
133.25
Close
137.20
Change
0.99%
LDCP
135.85
Volume
1,457
Total Trades
14
CIRCUIT BREAKER
122.27 — 149.44
DAY RANGE
133.25 — 137.20
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).

KEY PEOPLE
Erum Shakir RahimCEO
Lai Kuen GohChairperson
Agha Salman TaimurCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.pk.gsk.com

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Yousuf Adil, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
43,712,818.58
Shares
318,467,278
Free Float
63,693,456
Free Float
20.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2024Transmission of Quarterly Account for the Period Ended March 31, 2024 View   PDF
Apr 26, 2024Financial Results for the quarter ended March 31,2024 View   PDF
Apr 3, 2024Transmission of Annual Report for the year ended December 31, 2023 View   PDF
Mar 26, 2024GLAXO | GlaxoSmithKline Pakistan Limited FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 - GLAXO PDF
Oct 30, 2023Tranmission of Quarterly Report for the Period Ended September 30, 2023 View   PDF
Oct 24, 2023Financial Results for the Quarter Ended 30-09-2023 View   PDF
Aug 28, 2023Transmission of Quarterly Report for the Period Ended June 30, 2023 View   PDF
Aug 22, 2023GLAXO | GlaxoSmithKline Pakistan Limited Financial Results for the Half Year Ended June 30, 2023 PDF
May 3, 2023Transmission of Annual Report for the Year Ended December 31, 2022 View   PDF
Apr 28, 2023Transmission of Quarterly Report for the Period Ended March 31, 2023 View   PDF
DateTitleDocument
Apr 24, 2024Certified True Copy of Resolution passed by the Shareholders in the Annual General Meeting held on April 24, 2024 View   PDF
Apr 19, 2024Board Meeting for the quarter ended March 31, 2024 View   PDF
Apr 3, 2024GLAXO | GlaxoSmithKline Pakistan Limited - Notice of Annual General Meeting PDF
Mar 19, 2024Board of Directors Meeting - 4th Quarter 2023 on 26 March 2024 View   PDF
Oct 17, 2023Board Of Directors Meeting View   PDF
Aug 15, 2023Board Meeting View   PDF
May 24, 2023Certified True Copy of Resolution passed by the Shareholders in the Annual General Meeting held on May 24, 2023 View   PDF
May 3, 2023Notice of Annual General Meeting View   PDF
Apr 20, 2023Board of Directors Meeting View   PDF
Apr 20, 2023Notice of Annual General Meeting - Prior Publication View   PDF
DateTitleDocument
Apr 23, 2024GLAXO | GlaxoSmithKline Pakistan Limited Material Information PDF
Dec 13, 2023Presentation of Corporate Briefing Session - 2023 View   PDF
Dec 11, 2023GLAXO | GlaxoSmithKline Pakistan Limited- CORPORATE BRIEFING SESSION - 2023 PDF
Jun 2, 2023Material informaiton View   PDF
Jun 2, 2023Change of Company Secretary View   PDF
May 30, 2023Material Information - Resignation of Company Secretary View   PDF
May 17, 2023Notice of Election of Directors View   PDF
Apr 5, 2023RESCHEDULING OF AGM AND BOOK CLOSURE DATES View   PDF
Nov 24, 2022Notice of Corporate Briefing Session 2022 View   PDF
Sep 28, 2022Appointment of Non-Executive Director View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2023202220212020
Sales49,661,27741,841,58536,660,77235,090,112
Profit after Taxation533,9532,462,8925,354,4093,375,240
EPS1.687.7316.8110.60
Q1 2024Q3 2023Q2 2023Q1 2023
Sales15,616,12613,770,54411,860,20611,399,120
Profit after Taxation565,281(69,790)(752,393)430,562
EPS1.78(0.22)(2.36)1.35
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2023202220212020
Gross Profit Margin (%)7.0517.4026.5621.47
Net Profit Margin (%)1.085.8914.619.62
EPS Growth (%)(78.27)(54.02)58.5810.99
PEG(0.63)(0.21)0.141.65

Payouts

DateFinancial ResultsDetailsBook Closure
February 28, 2022 11:32 AM31/12/2021(YR) 70%(F) (D) 19/04/2022 - 25/04/2022
March 10, 2021 3:45 PM31/12/2020(YR) 65%(F) (D) 21/04/2021 - 27/04/2021
March 11, 2020 5:58 PM31/12/2019(YR) 60%(F) (D) 15/05/2020 - 21/05/2020
March 4, 2019 4:53 PM31/12/2018(YR) 70%(F) (D) 18/04/2019 - 24/04/2019
February 27, 2018 3:59 PM31/12/2017(YR) 40% (D) 18/04/2018 - 24/04/2018
October 26, 2017 5:47 PM30/09/2017(IIIQ) 30% (D) 10/11/2017 - 17/11/2017
March 8, 2017 4:03 PM31/12/2016(YR) 60% (D) 18/04/2017 - 24/04/2017
March 30, 2016 3:13 PM31/12/2015(YR) 40% (D) 20/04/2016 - 27/04/2016
February 25, 2015 3:51 PM31/12/2014(YR) 50% (D) 16/04/2015 - 23/04/2015
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014

Financial Reports